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Summary.-The effect of exogenous Namalva interferon (IF) on the natural killer
(NK) cell activity of human blood lymphocytes was examined against 5 target cell
lines (K562, CCRF/CEM, Molt 4, Raji and Bri8) using the 51Cr-release assay. Addition
of IF to the test significantly increased the cytotoxicity, though not as much as when
effector cells were treated with IF before the test. Augmentation of cytotoxicity was
evident after only 1 h pretreatment and was maximal by 6 h. The rate of lysis
of susceptible targets by IF-treated effectors markedly exceeded that by their un-
treated counterparts. Separation of lymphocyte subpopulations (by SRBC-rosette
sedimentation and nylon-fibre column filtration) demonstrated that the activities of
IF-stimulated and unstimulated cells were similarly distributed, suggesting that the
major effect of IF is enhancement of the activity of pre-existing NK cells rather than
generation of new populations of effectors. Target cell lines with high and low sus-
ceptibility to NK cells showed increased cytotoxicity by IF-treated effector cells.
These findings may be relevant to the current discussion of the role of NK cells in
immunosurveillance against neoplasia.
SINCE THEIR DISCOVERY by Isaacs &
Lindenmann (1957) as antiviral agents,
interferons have been shown over the
past decade to exert several biological
effects on cells (Gresser, 1977) in addition
to those associated with viral replication,
and may be induced by several non-viral
stimulae. Cumulative evidence indicates
that, among their diverse properties, inter-
ferons may have a regulatory influence on
several immune functions: suppression of
lymphocyte proliferation in response to
mitogens and alloantigens (Lindahl-
Magnusson et al., 1972a); inhibition in
vivo and in vitro of antibody formation to
T-cell-dependent and independent anti-
gens (Braun & Levy, 1972; Gisler et al.,
1974; Johnson et al., 1975; Sonnenfeld
et al., 1977) and enhancement of specific
cell-mediated cytotoxicity evoked by
tumour- and allo-antigens (Lindahl et al.,
1972b; Heron et al., 1976; Zarling et al.,
1978). Interferon may also stimulate other
effector-cell-mediated mechanisms such
as phagocytosis (Huang et al., 1971;
Donahoe & Huang, 1976) and nonspecific
cytotoxicity (Schultz et al., 1977; Einhorn
et al., 1978; Djeu et al., 1979; Senik et al.,
1979), act directly on various cell types to
inhibit their growth in vitro (Stewart
et al., 1976; Balkwill et al., 1978) and
modulate the expression of cell surface
antigens on lymphocytes and tumour cells
(Vignaux & Gresser, 1977).
It was recently shown that cells from
certain tumour-derived or virus-trans-
formed cell lines induce the production of
interferon when cultured together with
human or mouse lymphocytes (Trinchieri
et al., 1977, 1978). Two major effects were
ascribed to the interferon produced in
such mixed cultures: enhancement of
spontaneous cytotoxic activity of a sub-
population of normal human lymphocytes
(natural killer (NK) cells) hitherto identi-
fied as Fc (IgG)-positive, surface immuno-NATURAL CELL-MEDIATED CYTOTOXICITY IN MAN
globulin-negative, non-T lymphocytes,
against various virus-infected or tumour
cell lines; and an antagonistic inhibitory
effect on the susceptibility of the target
lines to cytotoxicity by both unstimulated
NK cells and those preincubated with
interferon (Trinchieri & Santoli, 1978).
In the present study the extent to
which the susceptibility of several target
cell lines to unstimulated NK cells could
be modified by exposure of effectors to
exogenous interferon was investigated.
In addition, properties of the effector
subpopulation and other features of the
lytic interaction are described. The inter-
feron for this purpose was derived from
lymphoblastoid Namalva cells which pro-
duce primarily leucocyte interferon (Stran-
der et at., 1975; Havell et al., 1977) cur-
rently underevaluation in clinicaltrials.
MATERIALS AND METHODS
Cell lines.-The following human cell lines
were used as targets: K562, recently reclassi-
fied as oferythroleukaemic derivation (Ander-
sson et al., 1979), Molt-4, a T-cell line estab-
lished from an acute lymphatic leukaemia
(Minowada et al., 1972), CCRF-CEM, a long-
term T-cell line, also originating from an
acute lymphocytic leukaemia (Foley et al.,
1965), Raji, derived from a Burkitts' lym-
phoma (Huber et al., 1976) and Bri8, a lym-
phoid cell line with B-cell characteristics
(obtained from Searle Diagnostics, High
Wycombe, England). Cell lines were propa-
gated as suspension cultures in RPMI medium
containing 10% heat-inactivated foetal calf
serum (RPMI-FCS) and antibiotics.
Interferon.-Human lymphoblastoid inter-
feron, produced by Namalva cells, was pre-
pared and purified by Dr K. H. Fantes,
Wellcome Research Laboratories, Becken-
ham, Kent. Initially 3 preparations of differ-
ent specific activity were compared in this
study: Batches 669/15, 479/602 and 4645/6 of
specific activities 8-6 x 107, 2-2 x 106 and
5-8 x 105 reference units per mg protein
respectively. Units refer to British Standard
Unit calibrated against Std B69/19 (Natl
Inst. Biol. Stds Control, London). The
interferon, which contained added human
plasma protein as a stabilizer, was stored at
-70TC. Freshly thawed material was diluted
with RPM1-FCS before use.
Preparation and culture of effector cells.
Mononuclear cells obtained from heparinized
blood of normal donors were separated as
previously described (Potter & Moore, 1975)
substituting Ficoll-Paque (Pharmacia Fine
Chemicals, Sweden) for Ficoll Triosil in the
density-gradient centrifugation step. The
methods for separating subpopulations of
human lymphocytes have been recently
described (Potter & Moore, 1979). Briefly,
T-cell-enriched and depleted fractions were
obtained by separating lymphocytes rosetting
with sheep erythrocytes from non-rosetting
lymphocytes on a Ficoll-Paque gradient.
Erythrocytes were lyzed by brief exposure
to distilled water, and the degree ofseparation
achieved determined by re-rosetting samples
from the pellet and interface populations.
Lymphocytes were also separated into nylon-
fibre adherent and non-adherent populations
by column filtration.
For culturing lymphocytes in the presence
or absence ofinterferon (IF), cell suspensions
at 3 x 106/ml in RPMI-FCS were incubated
at 37TC in a humidified 5% C02 atmosphere.
At the end of the incubation, cells were
washed x 3 in Hanks's balanced salt solution
(HBSS), pH 7-2, their viability assessed by
trypan-blue exclusion, and resuspended in
RPMI-FCS. In some experiments IF was
added directly to the cytotoxicity assay.
Determination ofcell-mediated cytotoxicity.-
The cytotoxicity assay has been described in
detail previously (Potter & Moore, 1979).
Briefly, target cells were labelled with [51Cr]
sodium chromate (Radiochemical Centre,
Amersham) washed, and 104 cells added to
2-5ml plastic tubes in 0-2 ml of RPMI-FCS.
Effector to target (E:T) ratios of 20:1, 10:1
and 5:1 were used routinely. Spontaneous
isotope release was determined from control
tubes containing only target cells, and
maximum release byaddition ofTriton X 100
(1/100 dilution). All tests were set up in
triplicate and incubated for 6 h (unless other-
wise stated) at 37°C in an atmosphere of
95% air and 5% CO2. At the end of the
incubation period the tubes were centrifuged
and 0-2ml samples of the supernatant were
removed and, in addition to the residual
supernatant and pellet, counted on a Searle
1185 gamma counter. The percentage 51Cr
release was determined for each tube, and
using the mean value of triplicate tubes the
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percentage cytotoxicity calculated according
to the following formula:
% cytotoxicity=
(% 5lCr release in sample-
% 51Cr release in medium)
(% 51Cr release in Triton- x 100
% 51Cr release in medium)
Background isotope release over 6 h was
5-15% for all cell lines. Results are also
expressed as lytic units/106 cells, where one
lytic unit is defined as the number of effector
cells required to produce 30% cytotoxicity
above the baseline, calculated from dose-
response curves.
RESULTS
Effect of IF on natural cytotoxicity against
K562 cells
The relative cytotoxicities ofunstimula-
ted effectors, effectors pretreated with IF
and the effect ofadding IF directly to the
cytotoxicity test, are shown in Fig. 1,
which is representative ofresults obtained
on more than 20 preparations of mono-
nuclear cells from normal human peri-
pheral blood. Addition of IF (250 iu/ml)
to the test system resulted in a significant
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FIG. 1. The effect of interferon on the
spontaneous cytotoxicity of blood lyrnpho-
cytes for K562 target cells. Interferon
(250 u/ml) was added to the test system
(-), or used to pretreat effector cells for
18 h (X) and the results compared with
untreated effector cells (0).
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FIG. 2. Potentiation of cytotoxic activity of
blood lymphocytes from a single donor
against K562 cells by 3 different interferon
preparations: *, Batch 669/15, sp. act
8-6 x 107 iu IF/mg protein; I1, Batch 479/
602, sp. act 2-2 x 106 iu/mg; *, Batch
4645/6, sp. act. 5-8 x 105 iu/mg. Lympho-
cytes pre-incubated for 18 h at 37°C.
0, control lymphocytes, preincubated for
18 h without IF. Effector: target cell ratio,
20:1; other ratios gave similar results.
increase in cytolytic activity, over that of
unstimulated preparations (e.g. 65% vs
49% at E:T ratio 20:1). However, these
levels were invariably surpassed when the
effectors were treated with IF (250 iu/ml
for 18 h) before the test (e.g. 75% at E:T
ratio 20:1).
The 3 interferon preparations increased
cytotoxicity against K562 cells to vir-
tually identical levels in a dose-dependent
manner, over a concentration range of 3
decades (Fig. 2). Enhanced cytotoxicity
was detectable at 10 iu/ml and reached a
plateau at 250-500 iu/ml. A standard con-
centration of 250 iu/ml of the IF prepara-
tion (479/602) of intermediate specific
activity (2.2x 106 iu/mg protein) was
therefore adopted in all subsequent experi-
ments.
The cytotoxic potential of effector cells
as a function of time of exposure to IF
was examined and compared with un-
treated controls incubated alone for iden-
tical periods. Significant enhancement was
usually detected after only 1 h pre-
incubation with IF, but maximal values
380U L- .z
TABLE I.-The effect of interferon treatment on cytotoxicity of different target cell lines
I
Intei-feroii treatment.(250 u/ml)
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I
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Fia. 3.--Cytotoxic activity of bloo(I lymplio-
cytesagainst, K562 cells as aftinction oftime
ofpre4reatment, with intei-feron (250u/ml).
Effector:target cell ratios of 20:1 (0) an(i
10:1 (,&). Cytotoxicity values at zero time,
are those for control lympliocytes pre-
incubated for 18 li without interferon.
were not reached until 6 h. Cytotoxicity at
18 h was equivalent to, or slightly less
than that observed at 6 h (Fig. 3).
The kinetics of the lytic interaction
between IF-stimulated and unstimulated
effectors was examined in cytotoxicity
assays of variable duration. Early in the
test, IF pre-treated effectors were clearly
the most cytolytic (Fig. 4), enhanced
cytotoxicity (52% v8 23%) being detect-
able by I h. Reactivity thereafter in-
creased to a maximum (70%) at 6 h and
i-emained unchanged by 18 h. Maximal
levels of cytotoxicity were not seen for
tintreated effectors until 18 h, at which
time their activity was comparable (66%)
101
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4.-K'neties of cytotoxieity to K562
target cells by interferon-treated blood
lymphocytes. Interferon was adde(i to the
test system (A), or used to pretreat effector
cells (250 u/ml; 18 h; 37'C) (X) and
the resultscompare(I witli tintreate(ieffector
cells (0). Effector:target cell ratio 20: 1.
with that of pre-treated effectors (70%).
A similarprofile ofreactivity was obtained
when IF was added to the test, but with
higher levels of cytotoxicity at all sample
times after 1. h. Under these latter condi-
tions, cytotoxicity at 18 h (83%) exceeded
that in which effectors were pretreated
with IF, representing a reversal of their
respective activities in tests of shorter
duration.
Target-cell MSCeptibility
The susceptibilities of 4 more cell Iiiies
were compared under conditions identical
18h Pretreatment of
effectors
20:1 10:1 5:1
68-6 51.9 31-0
66-5 56-2 31-2
62-1 50.9 27-8
38-1 26-8 16-7
33-0 20-5 13-5
Target cell
K562
Afolt 4
CCRF/CE.AI
Bri8
Raji
None
20:1 * 10:1 5:1
42-1 27-1 17-6
53-3 40-5 24-4
45-0 32-1 18-6
10.0 9-5 6-1
2-0 0-8 0.5
Added to test
20:1 10:1 5:11
53-3 43-5 30-4
61-8 48-2 29-6
53-7 40-2 21-7
21-4 19-7 10.8
9-7 6-6 5-3
* Effector:target cell ratio.382 M. MOORE AND M. R. POTTER
of stimulated and unstimulated effectors
in lymphocyte subpopulations. For this
purpose, lymphocytes were fractionated
by two methods: density-gradient separa-
tion of SRBC-rosette-formino, cells (RFC)
and nylon-fibre column filtration. Lym-
phocytes separated by Ficoll-Paque den-
sity-gradient centrifugation after rosette
formation with SRBC yielded pellet and
interface populations comprising between
85%-90% and 5%-10% RFCrespectively
(determined by re-rosetting). Pellet, inter-
face and control (unfractionated) popula-
tions were thereafter tested for cytotoxic
activity under the 3 test conditions. Fig. 5
shows the results of a typical experiment
using K562 target cells in a 6h cyto-
toxicity test. Cytotoxic activity was
preseiit in all 3 populations, but with
somewhat greater activity in the interface
and unseparated population (both giving
40% cytotoxicity at a ratio of 20:1) than
in the pelletpopulation (28% cytotoxicity
at 20:1) when tested using equal numbers
of effector cells. IF treatment produced a
considerable increase in activity in all 3
populations, with a greater effect from
pretreatment of effector cells with inter-
feron thanby inclusion ofinterferon in the
test system.
Similar results were obtained with
NK susceptible Molt 4 target cells sum-
marized in Table 11). Bri8 target cells, on
the other liand, gave low levels of cyto-
toxicity with all 3 effector populations
(7-10% cytotoxicity at a ratio of 20:1)
with no IF treatmeDt. Inclusion of IF in
the testproduced some increase in activity
in all 3 populations (13-21% cytotoxicity
at 20:1) but pretreatment oflvmphocytes
was most effective, particularly in respect
of the activities of the interface and con-
trol populations (53% and 45% cyto-
toxicity respectively at 20:1 ratio) which
weregreater than that ofthepelletpopula-
tion (33% cytotoxicity). Summary data
for Bri8 expressed in lytic units are given
in Table 11.
Examination of the data in Table 11 for
K562 and Molt 4 targets, shows that the
44enhancement ratio" (defined as 1F-
007
-40
V
Fic.. 5.-Cytotoxicity to K562 target cells by
interferon-treated blood-lymphocyte pre-
parations separated by SRBC-rosette sedi-
mentation. Effector cells were separate(I
into pellet, interface and control (un-
separated) populations and tested for cyto-
toxicity after pretreatment with interferon
('250u/ml; 18h; 37'Q (X), orwith interferon
added to the testsystem(,&), and the results
compared with untreated effector cells
(0). Effector:target cell ratio 20:1.
to those for the study of K562 (Table 1).
The two T-cell lines Molt-4 and CCRF/
CEM were susceptible to lysis by un-
stimulated effectors (53% and 45% cyto-
toxicityrespectively, at E:T ratio 20:1) to
a degree comparable with K562 (42%).
By contrast, the B-cell linesRaji and Bri 8
were highly refractory (10% and 2%
cytotoxicity respectively). As for K562,
addition ofIF to the test system produced
a marked increase in cytotoxicity (e.g.
from 53% to 62% forMolt-4, at E:T ratio,
20:1) though not so great as when the
effectors were pretreated with IF (67%).
Particularly significant was the finding
that, under these optimal conditions of
effector-cell stimulation, the resistant lines
became made susceptible to lysis, to a
degree (33-38% at E:T ratio 20:1)
approaching that of other cell lines
exposed to unstimulated effectors (42-
53%).
Effect ofIF on cytotoxicactivity of
lymphocyte 3ubpopulation8
The nature of the cells inediatiiig aug-
mented IF-induced cytolysis was studied
by comparison of the cytotoxic activitiesNATURAL CELL-MEDIATED CYTOTOXICITY IN MAN
TABLE II.-The effect of interferon treatment on cytotoxicity of K562 target cells by blood
lymphocyte preparations separated by SRBC rosette separation
Lytic units/106 cells*
Interferon
Effector treatment
population (250 u/ml)
Unseparated None
Pretreatment (18 h)
In test
Pellet None
Pretreatment (18 h)
In test
Interface None
Pretreatment (18 h)
In test
Experiment 1 Experiment 2
K562 Molt 4 K562 Bri8
20*0
35.7
30-3
7-9
14*5
17-5
27-0
41*7
38*5
22*2 7*4 < 1 0
33.3 26.3 13-0
31-3 14*1 1.6
13-0
16*9
21-7
20-4
25-6
NT
4-6
11-2
6-8
7-8
37 0
13-5
<1-0
5.4
<1-0
<1-0
21-3
1-7
* Required for 30% cytotoxicity.
NT =Not tested.
induced cytotoxicity in lytic units (LU) .-
spontaneouscytotoxicityinLU) is constant
for unseparated, pellet and interface
effector populations (e.g. 35.7/20-0= 1-8,
14-5/7.9=1l8 and 41.7/27'0=15 for the
respective IF pretreated fractions against
K562-Expt. 1) indicating that NK cells
and IF activated cells are associated with
the same fractions. Although the distribu-
tion of effector function between the
various fractions was comparable against
10 - I S *
Ot ,- I- L _ . , ,0
51 10:1 20:1 5:1 1011 20:1 5:1 10-1 20:1
Efleclor toarclet cell ratio
FIG. 6.-Cytotoxicity to K562 target cells
by interferon-treated blood-lymphocyte
preparations separated by nylon-fibre
columnfiltration. Effector cells were separa-
ted into non-adherent, adherent and
control (unseparated) populations and
tested for cytotoxicity activity after pre-
treatment with interferon (250 u/ml;
18 h; 37°C) (X), or with interferon added
to the test system (A), and the
results compared with effector cells not
treated with interferon (*). Effector:
target cell ratio, 20:1.
Bri8, corresponding ratios could not be
calculated on account of the very low
activity in the unstimulated populations
(<1 LU/106 cells).
Lymphocytes were also separated by
nylon fibre column filtration to give a
non adherent (column passed) population
and an adherent population recovered
from the column. Non adherent, adherent
and control (unseparated) populations
were tested for cytotoxic activity under
the 3 test conditions. Fig. 6 shows the
results ofa typical experiment using K562
target cells. Nylon-fibre column filtration
gave a non adherent population with
cytotoxic activity equal to or greater than
the control population and an adherent
population with lower activity. All 3
populations showed increased activity
withIFtreatment, andagainpretreatment
of effector cells produced a larger effect
than adding IF to the test.
Using Molt-4 and Bri8 targets, a similar
pattern of results was obtained, but with
lower levels of cytotoxicity against the
latter (Table III). Non-adherent cells
showed predictably greater cytotoxic acti-
vity than adherent cells but IF treatment
considerably increased the reactivity in
all effector populations.
Enhancement ratios calculated for each
population, as described above, were again
comparable, at least for data on K562 and
Molt 4.
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TABLE III.-The effect of interferon treatment on cytotoxicity of K562 target cells by
blood lymphocyte preparations separated by nylonfibre columnfiltration
Effector Interferon
population treatment
(250 u/ml)
Unseparated None
Pretreatment (18 h)
In test
Non-adherent None
Pretreatment (18 h)
In test
Adherent None
Pretreatment (18 h)
In test
* Required for 30% cytotoxicity.
NT=Not tested.
DISCUSSION
The release of viral inhibitors in the
supernatants ofmixed cultures oflympho-
cytes and certain tumour-derived or virus-
transformed cell cultures was recently
described by Trinchieri and colleagues
(Trinchieri et al., 1978; Trinchieri &
Santoli, 1978) who characterized them as
interferons. Two additional properties
were associated with these supernatants,
which correlated with their antiviral
activity; anticellular activity and a capa-
city to enhance spontaneous lymphocyte
cytotoxicity. Since such mixed cultures
furnish a plethora of biologically active
substances, it was not possible to conclude
definitively whether the various activities
were mediated by identical or different
molecules. As far as enhancement of
lymphocyte cytotoxicity was concerned,
the probability that IF was the active
principle was subsequently strengthened
by Herberman et al. (1979) and Zarling
et al. (1979) using purified preparations of
lymphoblastoid cell and fibroblast origins,
the latter having the advantage over pre-
parations derived from virus-infected or
antigen stimulated lymphocytes oflacking
virus products and lymphokines. We have
also now shown that partially purified
human lymphoblastoid IF, produced by
Namalva cells, enhances several fold the
Lytic units/106 cells*
Experiment 1 Experiment 2
K562 Molt 4 K562 Bri8
11-6
25-0
26-3
12-2
25-6
23-8
7.9
20-4
18-5
14-7
20-8
19-2
21-3
25-6
24-4
NT
NT
NT
8-4
20-8
20-4
15-9
29-4
24-4
5-1
12-3
12-2
<1-0
7-7
1-6
<1-0
7-1
3.3
<1-0
1-3
1-4
spontaneous cytotoxicity of human peri-
pheral bloodlymphocytes, notonlyagainst
susceptible, but also against refractory
in vitro targets. The close correlation of
cytotoxicity with interferon titre for the
3 preparations, differing as much as 150-
fold in specific activity, provides further
corroborative evidence that IF, as distinct
from some other lymphokine, is the active
agent in these experiments.*
The cytotoxic cells showing activity
enhanced by IF were characterized by
comparison ofthe activity oflymphocytes
separated by two techniques: adherence to
nylon fibre columns and formation of
SRBC rosettes. Thedemonstrationthatthe
activity of the IF stimulated and un-
stimulated cells were similarly distributed
strongly suggested that the same cells
were involved in both cytotoxic pheno-
mena. We have previously shown that cells
with spontaneous cytotoxic activity are
heterogeneous, since their activity is
present in SRBC-rosette-forming and non-
rosette-forming fractions and nylon-fibre
adherent and non-adherent fractions
(Potter & Moore, 1979). The action of IF
would thus appear to be not the generation
of a new population of effectors, but an
increase in the activity of pre-existing
NK cells (Saksela et at., 1979) manifest
against all the cell lines tested, whether of
* In this eontext, it is pertinent to note that both crude and partially purified Namalva IF have no migra-
tion inhibitory factor (MIF) activity (Fantes, K.H., personal communication).
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high or low susceptibility to unstimulated
NK cells.
Enhancement of cytotoxicity was most
apparent when effectors were pre-treated
with IF and washed before addition to the
test. Theresponsewasvirtuallyimmediate,
enhanced cytotoxicity being easily detect-
able after 1 h and maximal after 6 h. The
rapidity of this interaction excludes pro-
liferation of a clone of NK cells as an
explanation of our findings, and corrobor-
ates our interpretation that the action of
IF is to amplify the activity of pre-
existing NK cells or their precursors.
The activity of IF-pre-treated effectors
also shows that IF probably does not act
by providing a recognition-binding sys-
tem (as is the function ofIgG molecules in
the induction of antibody-dependent cel-
lular cytotoxicity) but directly stimulates
effector cells. The mechanism whereby IF
augments NK activity is not known and
it remains to be determnined whether the
multiple effects ascribed above to IF are
mediated by a common pathway.
The efficacy of NK stimulation by IF
was also reflected in the kinetics of cyto-
toxicity, where stimulated effectors exer-
ted their lytic activity earlier and more
strongly than their untreated counter-
parts. The high levels of cytotoxicity
achieved after 18 h by control effectors
in the absence of exogenous IF may be
related to the endogenous generation of
IF by lymphocytes exposed to K562
cells (Fantes & Moore, unpublished; cf.
Trinchieri et al., 1977).
Addition of IF to effector:target cell
mixtures, as distinct from pre-treatment
of effectors alone, also increased cyto-
toxicity, but to a lesser extent. Reduced
availability of IF to effectors, leading to
sub-optimal stimulation on account of
competitive interaction with targets, is
possible, if unlikely, at the E :T ratios
used. The probable explanation is that
IF exerts an antagonistic effect on targets.
Indeed, IF-pretreated targets are more
resistant than their untreated counter-
parts to lysis by both IF-treated and
untreated NK cells (unpublished observa-
tions). This accords with the data of
Trinchieri & Santoli (1978) on certain
targets, when an indirect intracellular
mechanism was postulated involving syn-
thesis by the cells of both RNA and
protein.
Other conditions under which NK
activity is augmented in vitro may be
relevant to our findings. Several studies
have shown that hunman lymphocytes kill
virus-infected targets more efficiently than
their uninfected counterparts (Santoli et
al., 1978a, b). The high level of IF pro-
duced in these systems is held to be the
major factor responsible for the increase
in susceptibility. During the generation of
cytotoxic T lymphocytes in mixed culture
by allogeneic lymphocytes, B-cell lines
and tumour cells (Peter et al., 1975;
Jondal & Targan, 1978; Koide & Taka-
sugi, 1978) there is a concurrent increase
in the level of natural cytotoxicity. This
is probably caused by the product of an
activated lymphocyte (or macrophage)
since supernatants from such activated
cultures augment NK activity in unstimu-
lated lymphocytes. In some of these
studies the kinetics of generation of cyto-
toxic cells resembles that obtained on IF
stimulation. These phenomena could thus
conceivably be mnediated, at least in part,
by endogenous IF, which, among other
activated lymphocyte products, is present
in such fluids.
It has been argued that interferon, as a
potent stimulator of natural cytotoxicity,
might render the NK system an inducible
selective defence mechanism against trans-
formed and virus-infected cells (Trinchieri
& Santoli, 1978). Both types of cell have
been shown to induce endogenous IF
production on contact with host lympho-
cytes in vitro (Trinchieri et al., 1977) and
this interaction could also be a mechanism
whereby NK activity is enhanced in vivo.
Generation of IF as an important factor
in host defences has recently gained sup-
port from, among other studies, animal
experiments inwhichdifferentanti-tumour
agents putatively acting via the common
pathway of IF induction have been shown
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to augment NK activity in vivo (Oehler
etal., 1978). That IF augmentsNKactivity
in manwasrecently shownby Huddlestone
et al. (1979) in studies of patients with
non-Hodgkin's lymphoma.
In this context the demonstration that
IF induces cytotoxicity against cells
which are refractory to lysis by unstimu-
lated effectors is potentially significant.
However, in our view, other issues are
also crucial to this hypothesis, including:
(i) that the documented antagonism of IF
toward target cells does not nullify the
enhanced cytotoxicity; and (ii) that spon-
taneously arising malignant cells that
have not been adapted to tissue culture
may be lysed by either native or activated
NK cells. To these questions, subsequent
reports from this laboratory will be
addressed (Vose & Moore, 1980).
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